Results 71 to 80 of about 2,702,342 (191)

Long‐term outcomes of apixaban as main anticoagulant in patients with HeartMate 3 left ventricular assist devices

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 1714-1718, June 2025.
Abstract Aims HeartMate 3 (HM3) left ventricular assist devices (LVADs) offer improved haemocompatibility‐related outcomes for end‐stage heart failure patients, facilitating the exploration of alternative anticoagulation therapies beyond warfarin.
Jennifer Jdaidani   +7 more
wiley   +1 more source

Organized intra-atrial thrombus in growing premature infant [PDF]

open access: yes, 2009
This article reports interesting echocardiographic images of the atrial septum in two growing premature infants related to the previous use of umbilical venous lines in the neonatal period.
Kazi, A.   +2 more
core  

Study on the effect of location of intracranial arterial stenosis on the safety of stenting

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2017
Objective To investigate the effect of location of intracranial arterial stenosis on the safety of intracranial stenting. Methods A total of 73 patients with symptomatic intracranial atherosclerotic stenosis (ICAS) were divided into intracranial internal
Yu-jie SUN   +4 more
doaj  

Heart failure, dementia is associated with increased stroke severity, in‐hospital mortality and complications

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 2066-2076, June 2025.
Abstract Background Heart failure (HF) is a risk factor for ischemic stroke. Cognitive impairment is very common in HF and stroke patients. Patients with HF have higher risk of developing dementia. However, there are limited studies investigating the characteristics, in‐hospital mortality and complications of stroke patients with both HF and dementia ...
Lijun Zuo   +6 more
wiley   +1 more source

Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events [PDF]

open access: yes, 2018
Five patients with paroxysmal nocturnal haemoglobinuria and thrombotic complications under oral antithrombotic treatment with vitamin K antagonist were switched to receive the direct oral anticoagulant rivaroxaban an factor Xa inhibitor.
Cafolla, Arturo   +4 more
core   +1 more source

Efficacy and safety of non‐vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation and kidney failure under hemodialysis: A meta‐analysis of controlled randomized trials

open access: yesJournal of Arrhythmia, Volume 41, Issue 3, June 2025.
Rivaroxaban or apixaban is as safe and effective as VKAs in patients with AF and kidney failure with hemodialysis. Even on oral anticoagulants, these patients remain at high risk of cardiovascular events and all‐cause mortality. Integrated care and holistic management are important for this high‐risk population. Abstract Background Atrial fibrillation (
Ting‐Yung Chang   +9 more
wiley   +1 more source

Management of anticoagulant-related intracranial hemorrhage: An evidence-based review [PDF]

open access: yes, 2014
The increased use of anticoagulants for the prevention and treatment of thromboembolic diseases has led to a rising incidence of anticoagulant-related intracranial hemorrhage (AICH) in the aging western population. High mortality accompanies this form of
Keyrouz, Salah G, Ray, Bappaditya
core   +3 more sources

Restoration of Glymphatic Influx After Photothrombotic Stroke Using Low‐Intensity Focused Ultrasound

open access: yesCNS Neuroscience &Therapeutics, Volume 31, Issue 6, June 2025.
We examine immediate effect and 7‐day LIFU on CSF influx in stroke mice. LIFU rapidly increased CSF influx, peaking at 20–30 min post‐stimulation. Stroke reduced CSF influx, lowest at day 1‐3, with recovery by day 7. Daily contralesional LIFU restored CSF influx, suggesting stroke recovery benefits.
Ming‐Yen Hsiao   +5 more
wiley   +1 more source

Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 3, Page 183-202, May/June 2025.
Abstract Despite the advances in cancer prevention, early detection, and treatments, all of which have led to improved cancer survival, globally, there is an increased incidence in cancer‐related deaths. Although each patient and each tumor is wholly unique, the tipping point to incurable disease is common across all patients: the dual capacity for ...
Kenneth J. Pienta   +2 more
wiley   +1 more source

Embolic strokes of undetermined source: prevalence and patient features in the ESUS Global Registry [PDF]

open access: yes, 2016
Background: Recent evidence supports that most non-lacunar cryptogenic strokes are embolic. Accordingly, these strokes have been designated as embolic strokes of undetermined source (ESUS).
Ameriso, Sebastian F   +27 more
core   +2 more sources

Home - About - Disclaimer - Privacy